Pancreas Cancer
329
98
127
91
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
29 trials with published results (9%)
Research Maturity
91 completed trials (28% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.8%
29 terminated out of 329 trials
75.8%
-10.7% vs benchmark
4%
14 trials in Phase 3/4
32%
29 of 91 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 91 completed trials
Clinical Trials (329)
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
A Study of MGC026 in Participants With Advanced Solid Tumors
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
Pancreatic Cancer Early Detection Consortium
Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo Plateform
Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy